OBJECTIVES: To better understand care patterns and quality of life amongst eczema patients and explore potential differences associated with dermatologist access. METHODS: UK patients were invited to complete an on-line screener for the study based on: self-reported eczema, use of Rx/OTC treatment, and consultation with a doctor.  Eligible subjects proceeded to a 32 question survey; successful completers received £10. RESULTS: We screened 258 adults to obtain 100 completed surveys between 25 May and 1 June.  Although 65% were diagnosed 10+ years ago, 74% report it is difficult, very difficult, or extremely difficult to manage their condition.  Eczema has a very or extremely large effect on a patient’s life for 41%; an additional 32% experience a moderate effect based on the Dermatology Quality of Life Index.  69% of respondents report asking their GP for referral to a dermatologist, but 47 of 69 were ultimately referred (68%).  While there are some similarities between GP and dermatology visits (e.g., description of medicine and associated side effects), individuals visiting a dermatologist report: longer visit duration (68% spent 10+ minutes vs. 10% GP, p=<0.001); discussions of eczema cause (62% Derm vs. 30% GP, p =0.0012); description of eczema symptoms (68% Derm vs. 38% GP, p=0.0018); and training on moisturizer application (94% Derm vs. 64% GP, p=0.0007).  Although differences in care exist, there was no apparent difference in severity between those patients referred vs. not referred to a dermatologist, nor was there an apparent difference in education, age, gender, income or employment status. CONCLUSIONS: This study demonstrates the impact of eczema on patient QoL, and differences in management between GPs and dermatologists highlighted by more education by dermatologists. Previous studies have demonstrated that more education leads to better outcomes. Standardising referral guidelines by including the DLQI may lead to more appropriate referrals and optimized patient management.